Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 21, which means every article in Clinical Investigation has got 21 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

  2020 2019 2018 2017 2016

Year wise published articles

28 19 22 19 2

Year wise citations received

222 233 233 230 181
Journal total citations count 1936
Journal impact factor 6.44
Journal 5 years impact factor 12.56
Journal cite score 10.78
Journal h-index 21
Journal h-index since 2016 18
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • Cheung SH, Zhang LX, Hu F, Chan WS (2014) Covariate-adjusted response-adaptive designs for generalized linear models. Journal of Statistical Planning and Inference 149: 152-161.

    View at Publisher | View at Google Scholar
  • Gaile DP, Miecznikowski JC (2013) From small studies to precision medicine: prioritizing candidate biomarkers. Genome medicine 5: 104.

    View at Publisher | View at Google Scholar
  • Hyun SW, Huang T, Zhu H (2015) Efficient and Ethical Adaptive Clinical Trial Designs to Detect Treatment–Covariate Interaction. InModern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects: 309-326.

    View at Publisher | View at Google Scholar
  • Sverdlov O (2015) An Overview of Adaptive Randomization Designs in Clinical Trials. InModern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects: 3-44.

    View at Publisher | View at Google Scholar
  • Sigaux F (2015) “Digital patient” in hematology and cancerology. Hématologie 21: 60-69.

    View at Publisher | View at Google Scholar
  • Liu, Stephen V., et al. "Genomics-based early-phase clinical trials in oncology: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies." European Journal of Cancer 50.16 (2014): 2747-2751. View at Publisher | View at Google Scholar | View at Indexing
  • Ballantyne A, Rogers W. Pregnancy, vulnerability, and the risk of exploitation in clinical research. InClinical research involving pregnant women 2016 (pp. 139-159). Springer International Publishing.

    View at Publisher | View at Google Scholar
  • Baylis F, MacQuarrie R (2016) Why physicians and women should want pregnant women included in clinical trials. InClinical research involving pregnant women: 17-31.

    View at Publisher | View at Google Scholar
  • Ells C, Lyster C (2016) Research ethics review of drug trials targeting medical conditions of pregnant women. InClinical research involving pregnant women: 95-118.

    View at Publisher | View at Google Scholar
  • Kaposy C (2016) Presumptive inclusion and legitimate exclusion criteria. InClinical research involving pregnant women: 51-62. Springer International Publishing.

    View at Publisher | View at Google Scholar
  • Schmidt AF, Groenwold RH, Van Delden JJ, Van Der Does Y, Klungel OH, et al. (2014) Justification of exclusion criteria was underreported in a review of cardiovascular trials. Journal of clinical epidemiology 67: 635-644.

    View at Publisher | View at Google Scholar
  • Clemow DB, Dewulf L, Michaels DL, Nolan MR, Cantrell SA (2014) A proposed framework to address needs of clinical data for informed medication use in pregnancy. Therapeutic Innovation & Regulatory Science 48: 145-154.

    View at Publisher | View at Google Scholar
  • Matsui D (2015) Ethics of studies of drugs in pregnancy. Pediatric Drugs 17: 31-35.

    View at Publisher | View at Google Scholar
  • Clemow DB, Dewulf L, Koren G, Mikita JS, Nolan MR, et al. (2014) Clinical data for informed medication use in pregnancy: strengths, limitations, gaps, and a need to continue moving forward. Therapeutic Innovation & Regulatory Science 48: 134-144.

    View at Publisher | View at Google Scholar
  • Baylis F, Ballantyne A (2016) Missed trials, future opportunities. InClinical research involving pregnant women: 1-13.

    View at Publisher | View at Google Scholar
  • Clemow DB, Nolan MR, Michaels DL, Kogelnik AM, Cantrell SA, et al. (2015) Dewulf L. Medicines in pregnancy forum: Proceedings on ethical and legal considerations. Therapeutic Innovation & Regulatory Science 49: 326-332.

    View at Publisher | View at Google Scholar
  • Briggs GG, Polifka JE, Wisner KL, Gervais E, Miller RK, et al. (2015) Should pregnant women be included in phase IV clinical drug trials?. American journal of obstetrics and gynecology 213: 810-815.

    View at Publisher | View at Google Scholar
  • Ravinetto R, Schwartz L (2016) Research Ethics Governance in Times of Ebola. PUBLIC HEALTH 1: 13.

    View at Publisher | View at Google Scholar
  • Schopper D, Ravinetto R, Schwartz L, Kamaara E, Sheel S, et al. (2016) Research Ethics Governance in Times of Ebola. Public Health Ethics 1: 039.

    View at Publisher | View at Google Scholar
  • Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, et al. (2012) Early management of severe traumatic brain injury. The Lancet 380: 1088-1098. View at Publisher | View at Google Scholar | View at Indexing
  • Lingsma H, Andriessen TM, Haitsema I, Horn J, van der Naalt J, et al. (2013) Prognosis in moderate and severe traumatic brain injury: external validation of the IMPACT models and the role of extracranial injuries. Journal of trauma and acute care surgery 74: 639-646.

    View at Publisher | View at Google Scholar
  • Stein DG (2015) Embracing failure: what the phase III progesterone studies can teach about TBI clinical trials. Brain injury 29: 1259-1272. View at Publisher | View at Google Scholar | View at Indexing
  • Hutchison JS, Guerguerian AM (2013) Cooling of children with severe traumatic brain injury. The Lancet Neurology 12: 527-529.

    View at Publisher | View at Google Scholar
  • Paul F (2013) Hope for a rare disease: eculizumab in neuromyelitis optica. The Lancet Neurology 12: 529-531.

    View at Publisher | View at Google Scholar
  • Xiong Y, Zhang Y, Mahmood A, Chopp M (2015) Investigational agents for treatment of traumatic brain injury. Expert opinion on investigational drugs 24: 743-760.

    View at Publisher | View at Google Scholar
  • Bragge P, Synnot A, Maas AI, Menon DK, Cooper DJ, et al. (2016) A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury. Journal of neurotrauma 33: 1461-1478.

    View at Publisher | View at Google Scholar
  • Stein DG. Lost in translation: understanding the failure of the progesterone/traumatic brain injury Phase III trials.

    View at Publisher | View at Google Scholar
  • Nunn A, Bath PM, Gray LJ (2016) Analysis of the Modified Rankin Scale in Randomised Controlled Trials of Acute Ischaemic Stroke: A Systematic Review. Stroke research and treatment 20.

    View at Publisher | View at Google Scholar
  • Lazaridis C, Maas AI, Souter MJ, Martin RH, Chesnut RM, et al. (2015) Second Neurocritical Care Research Conference Investigators. Alternative Clinical Trial Design in Neurocritical Care. Neurocritical care 22: 378-384.

    View at Publisher | View at Google Scholar
  • Markovic G, Schult ML, Bartfai A (2016) The effect of sampling bias on generalizability in intervention trials after brain injury. Brain injury 6: 1-7.

    View at Publisher | View at Google Scholar
  • Staples JA, Wang J, Mills B, Temkin N, Zaros MC, et al. (2016) Jurkovich GJ, Rivara FP. The Application of the CRASH-CT Prognostic Model for Older Adults With Traumatic Brain Injury: A Population-Based Observational Cohort Study. The Journal of head trauma rehabilitation 31: 8-14.

    View at Publisher | View at Google Scholar
  • van Essen TA, De Ruiter GC, Kho KH, Peul WC (2016)Neurosurgical Treatment Variation of Traumatic Brain Injury: Evaluation of Acute Subdural Hematoma Management in Belgium and The Netherlands. Journal of neurotrauma..

    View at Publisher | View at Google Scholar
  • Gronbeck KR, Rodrigues CM, Mahmoudi J, Bershad EM, Ling G, (2016) Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?. Neurocritical care 25: 153-166.

    View at Publisher | View at Google Scholar
  • Roquilly A, Asehnoune K (2014) Traitement de l’hypertension intracrânienne post-traumatique: quel impact sur le devenir des patients?. InAnnales francaises d'anesthesie et de reanimation 1: 6-7.

    View at Publisher | View at Google Scholar
  • Flume PA, Van Devanter DR (2012) State of progress in treating cystic fibrosis respiratory disease. BMC medicine 10: 88.

    View at Publisher | View at Google Scholar
  • VanDevanter DR, Pasta DJ, Konstan MW (2014) Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012. The Journal of pediatrics 165: 1091-1097.

    View at Publisher | View at Google Scholar
  • VanDevanter DR, Kahle JS, O’Sullivan AK, Sikirica S, Hodgkins PS (2016) Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment. Journal of Cystic Fibrosis 15: 147-157.

    View at Publisher | View at Google Scholar
  • VanDevanter DR, Pasta DJ, Konstan MW (2015) Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis. Journal of Cystic Fibrosis 14: 763-769.

    View at Publisher | View at Google Scholar
  • Dasenbrook EC, Konstan MW, VanDevanter DR (2015) Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes. Journal of Cystic Fibrosis 14: 370-375.

    View at Publisher | View at Google Scholar
  • Dasenbrook EC, Konstan MW (2012) Inhaled hypertonic saline in infants and young children with cystic fibrosis 307: 2316-2317.

    View at Publisher | View at Google Scholar
  • Torphy TJ, Allen J, Cantin AM, Konstan MW, Accurso FJ, et al. (2015) Considerations for the conduct of clinical trials with antiinflammatory agents in cystic fibrosis. A Cystic Fibrosis Foundation Workshop Report. Annals of the American Thoracic Society 12: 1398-1406.

    View at Publisher | View at Google Scholar
  • VanDevanter DR, Morris NJ, Konstan MW (2016) IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis. Journal of Cystic Fibrosis 15: 372-379.

    View at Publisher | View at Google Scholar
  • Thornton CS, Brown EL, Alcantara J, Rabin HR, Parkins MD (2015) Prevalence and impact of S treptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study. BMC pulmonary medicine 15: 49.

    View at Publisher | View at Google Scholar
  • Szczesniak R, Turkovic L, Andrinopoulou ER, Tiddens HA (2016) Chest imaging in cystic fibrosis studies: What counts, and can be counted?. Journal of Cystic Fibrosis.

    View at Publisher | View at Google Scholar
  • Szczesniak R, Heltshe SL, Stanojevic S, Mayer-Hamblett N. Use of FEV 1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.

    View at Publisher | View at Google Scholar
  • Flume PA, VanDevanter DR. The challenges of maintaining momentum in CF drug development and approval.

    View at Publisher | View at Google Scholar
  • Uria, Agustinus Robert. "Capturing natural product biosynthetic pathways from uncultivated symbiotic bacteria of marine sponges through metagenome mining: A mini-review." Squalen Bulletin of Marine and Fisheries Postharvest and Biotechnology 10.1 (2015): 35-49. View at Publisher | View at Google Scholar | View at Indexing
  • Halvorsrud, Liv, and Mary Kalfoss. "Quality of life data in older adults: self-assessment vs interview." British Journal of Nursing 23.13 (2014): 712-721. View at Publisher | View at Google Scholar | View at Indexing
  • Harrington JA, Wheeler GM, Sweeting MJ, Mander AP, Jodrell DI (2013) Adaptive designs for dual-agent phase I dose-escalation studies. Nature Reviews Clinical Oncology 10: 277-288.

    View at Publisher | View at Google Scholar
  • Elsäßer A, Regnstrom J, Vetter T, Koenig F, Hemmings RJ, et al. (2014) Greco M, Papaluca-Amati M, Posch M. Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency. Trials 15: 383.

    View at Publisher | View at Google Scholar

Relevant Topics